Editorial Policy

We prioritise questions that help readers understand molecular mechanisms: what a gene does, how a pathway is regulated, how a mutation changes function, and why a biomarker may affect therapy or resistance. Pages are written for explanation, not for individual diagnosis or prescribing.

Material claims should be traced to primary research, systematic reviews, curated biological databases, clinical-trial records, regulatory labels, or recognised professional guidance. Dates, populations, cancer types, treatment settings, endpoints, and approval status must be stated narrowly enough to avoid applying a result outside the studied context.

AI may be used to organise information or generate a first-pass synthesis. It is not treated as a source. Curated pages are checked against linked references before publication; on-demand generated profiles are clearly labelled and excluded from search indexing unless they are later curated.

Content is updated when evidence, approvals, or important interpretations change. GeneAnalyses does not accept payment for favourable scientific conclusions. If sponsored or affiliate content is introduced in the future, it must be labelled at the point of use.